-
2
-
-
0027240597
-
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
-
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682.
-
(1993)
N Engl J Med
, vol.329
, pp. 673-682
-
-
-
3
-
-
0023864355
-
Thrombolysis in Myocardial Infarction (TIMI) trial - Phase I. Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
-
Rao A.K., Pratt C., Berke A., Jaffe A., Ockene I., Schreiber T.L., Bell W.R., Knatterud G., Robertson T.L., Terrin M.L. Thrombolysis in Myocardial Infarction (TIMI) trial - phase I. hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol. 11:1988;1-11.
-
(1988)
J Am Coll Cardiol
, vol.11
, pp. 1-11
-
-
Rao, A.K.1
Pratt, C.2
Berke, A.3
Jaffe, A.4
Ockene, I.5
Schreiber, T.L.6
Bell, W.R.7
Knatterud, G.8
Robertson, T.L.9
Terrin, M.L.10
-
4
-
-
0033869435
-
Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: A pooled analysis
-
Dasgupta H., Blankenship J.C., Wood G.C., Frey C.M., Demko S.L., Menapace F.J. Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors a pooled analysis . Am Heart J. 140:2000;206-211.
-
(2000)
Am Heart J
, vol.140
, pp. 206-211
-
-
Dasgupta, H.1
Blankenship, J.C.2
Wood, G.C.3
Frey, C.M.4
Demko, S.L.5
Menapace, F.J.6
-
5
-
-
2242477091
-
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
-
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 330:1994;956-961.
-
(1994)
N Engl J Med
, vol.330
, pp. 956-961
-
-
-
6
-
-
1842369101
-
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
-
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 336:1997;1689-1696.
-
(1997)
N Engl J Med
, vol.336
, pp. 1689-1696
-
-
-
7
-
-
0030918995
-
Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
-
Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina the CAPTURE study . Lancet. 349:1997;1429-1435.
-
(1997)
Lancet
, vol.349
, pp. 1429-1435
-
-
-
8
-
-
0032508297
-
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/ IIIa blockade
-
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/ IIIa blockade. Lancet. 352:1998;87-92.
-
(1998)
Lancet
, vol.352
, pp. 87-92
-
-
-
9
-
-
0035927988
-
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization
-
Topol E.J., Moliterno D.J., Herrmann H.C., Powers E.R., Grines C.L., Cohen D.J., Cohen E.A., Bertrand M., Neumann F.-J., Stone G.W., et al. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med. 244:2001;1888-1894.
-
(2001)
N Engl J Med
, vol.244
, pp. 1888-1894
-
-
Topol, E.J.1
Moliterno, D.J.2
Herrmann, H.C.3
Powers, E.R.4
Grines, C.L.5
Cohen, D.J.6
Cohen, E.A.7
Bertrand, M.8
Neumann, F.-J.9
Stone, G.W.10
-
10
-
-
0035897893
-
Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: The GUSTO IV-ACS randomised trial
-
Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation the GUSTO IV-ACS randomised trial . Lancet. 357:2001;1915-1924.
-
(2001)
Lancet
, vol.357
, pp. 1915-1924
-
-
-
11
-
-
0035897888
-
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial
-
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition the GUSTO V randomised trial . Lancet. 357:2001;1905-1914.
-
(2001)
Lancet
, vol.357
, pp. 1905-1914
-
-
-
12
-
-
0035928845
-
Abciximab readministration: Results of the ReoPro Readministration Registry
-
Tcheng J.E., Kereiakes D.J., Lincoff A.M., George B.S., Kleiman N.S., Sane D.C., Cines D.B., Jordan R.E., Mascelli M.A., Langrall M.A., et al. Abciximab readministration results of the ReoPro Readministration Registry . Circulation. 104:2001;870-875.
-
(2001)
Circulation
, vol.104
, pp. 870-875
-
-
Tcheng, J.E.1
Kereiakes, D.J.2
Lincoff, A.M.3
George, B.S.4
Kleiman, N.S.5
Sane, D.C.6
Cines, D.B.7
Jordan, R.E.8
Mascelli, M.A.9
Langrall, M.A.10
|